Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein

Y. Dening, T. Straßl, V. Ruf, P. Dirscherl, A. Chovsepian, A. Stievenard, A. Khairnar, F. Schmidt, F. Giesert, J. Herms, J. Levin, M. Dieterich, P. Falkai, DV. Weisenhorn, W. Wurst, A. Giese, F. Pan-Montojo

. 2022 ; 12 (1) : 21951. [pub] 20221219

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032133

Parkinson ́s disease (PD) pathology progresses throughout the nervous system. Whereas motor symptoms are always present, there is a high variability in the prevalence of non-motor symptoms. It has been postulated that the progression of the pathology is based on a prion-like disease mechanism partly due to the seeding effect of endocytosed-alpha-synuclein (ASYN) on the endogenous ASYN. Here, we analyzed the role of endogenous ASYN in the progression of PD-like pathology in vivo and in vitro and compared the effect of endocytosed-ASYN as well as paraquat and rotenone on primary enteric, dopaminergic and cortical neurons from wild-type and ASYN-KO mice. Our results show that, in vivo, pathology progression did not occur in the absence of endogenous ASYN. Remarkably, the damage caused by endocytosed-ASYN, rotenone or paraquat was independent from endogenous ASYN and related to the alteration of the host ́s mitochondrial membrane potential. Dopaminergic neurons were very sensitive to these noxae compared to other neuronal subtypes. These results suggest that ASYN-mitochondrial interactions play a major role in initiating the pathological process in the host neuron and endogenous ASYN is essential for the transsynaptical transmission of the pathology. Our results also suggest that protecting mitochondrial function is a valid primary therapeutic target.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032133
003      
CZ-PrNML
005      
20230131151720.0
007      
ta
008      
230120s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-022-25790-2 $2 doi
035    __
$a (PubMed)36535974
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Dening, Yanina $u Department of Psychiatry, Ludwig-Maximilian University Hospital, Nußbaumstr. 7, 80366, Munich, Germany $u Department of Neurology, Ludwig-Maximilian University Hospital, Marchioninistr. 15, 81377, Munich, Germany
245    10
$a Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein / $c Y. Dening, T. Straßl, V. Ruf, P. Dirscherl, A. Chovsepian, A. Stievenard, A. Khairnar, F. Schmidt, F. Giesert, J. Herms, J. Levin, M. Dieterich, P. Falkai, DV. Weisenhorn, W. Wurst, A. Giese, F. Pan-Montojo
520    9_
$a Parkinson ́s disease (PD) pathology progresses throughout the nervous system. Whereas motor symptoms are always present, there is a high variability in the prevalence of non-motor symptoms. It has been postulated that the progression of the pathology is based on a prion-like disease mechanism partly due to the seeding effect of endocytosed-alpha-synuclein (ASYN) on the endogenous ASYN. Here, we analyzed the role of endogenous ASYN in the progression of PD-like pathology in vivo and in vitro and compared the effect of endocytosed-ASYN as well as paraquat and rotenone on primary enteric, dopaminergic and cortical neurons from wild-type and ASYN-KO mice. Our results show that, in vivo, pathology progression did not occur in the absence of endogenous ASYN. Remarkably, the damage caused by endocytosed-ASYN, rotenone or paraquat was independent from endogenous ASYN and related to the alteration of the host ́s mitochondrial membrane potential. Dopaminergic neurons were very sensitive to these noxae compared to other neuronal subtypes. These results suggest that ASYN-mitochondrial interactions play a major role in initiating the pathological process in the host neuron and endogenous ASYN is essential for the transsynaptical transmission of the pathology. Our results also suggest that protecting mitochondrial function is a valid primary therapeutic target.
650    _2
$a myši $7 D051379
650    _2
$a zvířata $7 D000818
650    12
$a alfa-synuklein $7 D051844
650    _2
$a rotenon $x terapeutické užití $7 D012402
650    _2
$a paraquat $7 D010269
650    12
$a Parkinsonova nemoc $x patologie $7 D010300
650    _2
$a dopaminergní neurony $x patologie $7 D059290
655    _2
$a časopisecké články $7 D016428
700    1_
$a Straßl, Theresa $u Department of Neurology, Ludwig-Maximilian University Hospital, Marchioninistr. 15, 81377, Munich, Germany
700    1_
$a Ruf, Viktoria $u Center for Neuropathology Und Prion Research, Ludwig-Maximilian-Universität München, Feodor-Lynen Str. 23, 81377, Munich, Germany $u Munich Cluster for Systems Neurology, SyNergy, Munich, Germany
700    1_
$a Dirscherl, Petra $u Institute of Developmental Genetics, Helmholtz Zentrum, Munich, Germany
700    1_
$a Chovsepian, Alexandra $u Department of Psychiatry, Ludwig-Maximilian University Hospital, Nußbaumstr. 7, 80366, Munich, Germany
700    1_
$a Stievenard, Alicia $u University Lille, Inserm, CHU Lille, UMR-S 1172 - JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, 59000, Lille, France
700    1_
$a Khairnar, Amit $u Applied Neuroscience Research Group, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic $u National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Palaj, Gandhinagar, Gujarat, 382355, India
700    1_
$a Schmidt, Felix $u Center for Neuropathology Und Prion Research, Ludwig-Maximilian-Universität München, Feodor-Lynen Str. 23, 81377, Munich, Germany $u Munich Cluster for Systems Neurology, SyNergy, Munich, Germany
700    1_
$a Giesert, Florian $u Institute of Developmental Genetics, Helmholtz Zentrum, Munich, Germany
700    1_
$a Herms, Jochen $u Center for Neuropathology Und Prion Research, Ludwig-Maximilian-Universität München, Feodor-Lynen Str. 23, 81377, Munich, Germany $u Munich Cluster for Systems Neurology, SyNergy, Munich, Germany $u Deutsches Zentrum Für Neurodegenerative Erkrankungen, Feodor-Lynen Str. 17, 81377, Munich, Germany
700    1_
$a Levin, Johannes $u Department of Neurology, Ludwig-Maximilian University Hospital, Marchioninistr. 15, 81377, Munich, Germany $u Munich Cluster for Systems Neurology, SyNergy, Munich, Germany $u Deutsches Zentrum Für Neurodegenerative Erkrankungen, Feodor-Lynen Str. 17, 81377, Munich, Germany
700    1_
$a Dieterich, Marianne $u Department of Neurology, Ludwig-Maximilian University Hospital, Marchioninistr. 15, 81377, Munich, Germany $u Munich Cluster for Systems Neurology, SyNergy, Munich, Germany
700    1_
$a Falkai, Peter $u Department of Psychiatry, Ludwig-Maximilian University Hospital, Nußbaumstr. 7, 80366, Munich, Germany
700    1_
$a Weisenhorn, Daniela Vogt $u Institute of Developmental Genetics, Helmholtz Zentrum, Munich, Germany
700    1_
$a Wurst, Wolfgang $u Institute of Developmental Genetics, Helmholtz Zentrum, Munich, Germany $u Deutsches Zentrum Für Neurodegenerative Erkrankungen, Feodor-Lynen Str. 17, 81377, Munich, Germany $u Technische Universität München-Weihenstephan, 85764, Neuherberg/Munich, Germany
700    1_
$a Giese, Armin $u Center for Neuropathology Und Prion Research, Ludwig-Maximilian-Universität München, Feodor-Lynen Str. 23, 81377, Munich, Germany $u Munich Cluster for Systems Neurology, SyNergy, Munich, Germany
700    1_
$a Pan-Montojo, Francisco $u Department of Psychiatry, Ludwig-Maximilian University Hospital, Nußbaumstr. 7, 80366, Munich, Germany. francisco.pan-montojo@med.uni-muenchen.de $u Department of Neurology, Ludwig-Maximilian University Hospital, Marchioninistr. 15, 81377, Munich, Germany. francisco.pan-montojo@med.uni-muenchen.de $u Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. francisco.pan-montojo@med.uni-muenchen.de
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 12, č. 1 (2022), s. 21951
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36535974 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151715 $b ABA008
999    __
$a ok $b bmc $g 1891106 $s 1183468
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 12 $c 1 $d 21951 $e 20221219 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace